EGFR and cerebral small vessel disease: Therefore, NOTCH3 cysteine-sparing mutations located in the higher EGFr domains might represent an underrecognized risk factor for cerebral small vessel disease, suggesting the need for increased awareness and investigation into these variants’ impact on the disease’s pathology.